Bank of America
ADPT icon

Bank of America’s Adaptive Biotechnologies ADPT Stock Holding History

Bank of America’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,900
Closed -$140K – 6855
2020
Q2 		$140K Buy
+2,900
New +$106K ﹤0.01% 5481

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America's ADPT Position: Q1 2026 in Review

Bank of America increased its Adaptive Biotechnologies (ADPT) stake by 52% in Q1 2026, buying an estimated $6.72M and bringing the position to 1,227,917 shares worth $17M. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Bank of America first reported a position in ADPT in Q3 2019 and has held it in 27 quarters since. The position peaked at $23.9M in Q3 2025. 296 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Bank of America held 1,227,917 shares of Adaptive Biotechnologies worth $17M as of Q1 2026.
  • Bank of America bought 421,645 Adaptive Biotechnologies shares in Q1 2026, an estimated $6.72M.
  • Adaptive Biotechnologies made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2537 holding.
  • Bank of America first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 27 quarters since.
  • Bank of America's Adaptive Biotechnologies position peaked at $23.9M in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.